Company Overview and News

 
Sadbhav Engineering Limited - Allotment of Securities

2018-09-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SADBHAV 532710

 
Sadbhav Engineering Limited - Allotment of Securities

2018-09-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SADBHAV 532710

 
Sadbhav Engineering Limited - Updates

2018-09-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SADBHAV 532710

 
Sadbhav Engineering Limited - Credit Rating

2018-09-11 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SADBHAV 532710

 
LT Infotech, Kwality, Infosys, Greaves Cotton, HCL Tech top gainers among A group stocks

2018-09-04 moneycontrol
The market sentiment turned negative yet gain this Tuesday afternoon with the Nifty50 trading at 11,529, down 53 points while the Sensex is trading lower by 112 points at 38,199.
IPCALAB HCTHY 532504 532713 532710 532221 524494 SONATSOFTW HCLTECH 501455 NAVINFLUOR 532281 SADBHAV SAKUMA GREAVESCOT

 
D-Street Buzz: FMCG stocks fall dragged by Jubilant Food, HUL; IT stocks rally with Infosys up 3%, hits new 52-week high

2018-09-04 moneycontrol
The market sentiment is negative this Tuesday morning after the rupee slipped to yet another record low against the US dollar. The benchmark indices including the Nifty50 shed 42 points at 11,540 while the Sensex is trading lower by 86 points at 38,226.
500325 DABUR BRIGADE BRTQY TCHQY TTQQY 532755 DBRQY 532710 TATACHEM SYNDIBANK 500096 532483 500696 BRITANNIA 500770 502355 RLNIY SBAZ RELCAPITAL YYBKY 530005 ALBERTDA CNRYY TECHM 532276 TCS CANBK ANDHRABANK BALKRISIND 500825 RELIANCE 532418 HINDUNILVR 533155 TATACOMM NAUKRI TTNQY JUBLFOOD 532777 532540 RIGD JBLWY SADBHAV INDIACEM 500111 YESBANK UBNC 517354 HVLQY 532929 532648 524075 HAVELLS 501455 GREAVESCOT 500483

 
Sadbhav Engineering rises 2%, bags projects worth Rs 2,900cr

2018-08-31 moneycontrol
Shares of Sadbhav Engineering rose 2.5 percent intraday Friday as company bagged projects worth Rs 2,900 crore.
SADBHAV 532710

 
Sadbhav Engineering bags Rs 1,620 crore order from Maharashtra State Road Development

2018-08-31 moneycontrol
Sadbhav Engineering today said it has received letter of acceptance (LOA) from the Maharashtra State Road Development Corporation for road project worth Rs 1,620 crore.
SADBHAV 532710

 
Sadbhav Engineering Limited - Updates

2018-08-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SADBHAV 532710

 
Sadbhav Engineering Limited - Updates

2018-08-31 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SADBHAV 532710

 
Sadbhav Engineering Limited - Press Release

2018-08-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SADBHAV 532710

 
Sadbhav Engineering Limited - Outcome of Board Meeting

2018-08-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SADBHAV 532710

 
Sadbhav Engineering Limited - Financial Result Updates

2018-08-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SADBHAV 532710

 
Sadbhav Engineering Limited - Change in Auditors

2018-08-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SADBHAV 532710

 
Sadbhav Engineering Limited - Updates

2018-08-13 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
SADBHAV 532710

Related Articles

DMPI: DelMar Pharmaceuticals Analysis and Research Report

6h - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...